{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:26:09Z","timestamp":1762507569593,"version":"build-2065373602"},"reference-count":67,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.hoc.2018.08.004","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T20:18:20Z","timestamp":1543263500000},"page":"135-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Rare Cutaneous T-Cell Lymphomas"],"prefix":"10.1016","volume":"33","author":[{"given":"Fabiana","family":"Damasco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleg E.","family":"Akilov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2008","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","key":"10.1016\/j.hoc.2018.08.004_bib1"},{"issue":"4","key":"10.1016\/j.hoc.2018.08.004_bib2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.det.2008.05.008","article-title":"Subcutaneous panniculitic-like T-cell lymphoma and other primary cutaneous lymphomas with prominent subcutaneous tissue involvement","volume":"26","author":"Gallardo","year":"2008","journal-title":"Dermatol Clin"},{"issue":"1","key":"10.1016\/j.hoc.2018.08.004_bib3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/bjh.14402","article-title":"Clinical manifestations and pathogenesis of cutaneous lymphomas: current status and future directions","volume":"176","author":"Rubio-Gonzalez","year":"2017","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.hoc.2018.08.004_bib4","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1097\/PAS.0b013e31826a5038","article-title":"Cutaneous \u03b3\u03b4 T-cell lymphomas: a spectrum of presentations with overlap with other cytotoxic lymphomas","volume":"36","author":"Guitart","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.hoc.2018.08.004_bib5","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.hoc.2018.08.004_bib6","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1182\/blood-2002-05-1597","article-title":"Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma","volume":"101","author":"Toro","year":"2003","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2018.08.004_bib7","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1182\/blood-2007-04-087288","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases","volume":"111","author":"Willemze","year":"2008","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.hoc.2018.08.004_bib8","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/cup.12091","article-title":"Indolent course of cutaneous gammadelta T-cell lymphoma","volume":"40","author":"Endly","year":"2013","journal-title":"J Cutan Pathol"},{"issue":"2","key":"10.1016\/j.hoc.2018.08.004_bib9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.hoc.2016.11.004","article-title":"Uncommon variants of T-cell lymphomas","volume":"31","author":"Mehta-Shah","year":"2017","journal-title":"Hematol Oncol Clin North Am"},{"issue":"8","key":"10.1016\/j.hoc.2018.08.004_bib10","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/archderm.136.8.1024","article-title":"Gamma delta T-cell lymphoma of the skin: a clinical, microscopic, and molecular study","volume":"136","author":"Toro","year":"2000","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.hoc.2018.08.004_bib11","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/1523-1747.ep12470953","article-title":"Primary cutaneous gamma\/delta T-cell lymphoma presenting as disseminated pagetoid reticulosis","volume":"96","author":"Berti","year":"1991","journal-title":"J\u00a0Invest Dermatol"},{"issue":"3","key":"10.1016\/j.hoc.2018.08.004_bib12","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/cup.12066","article-title":"Cutaneous EBV-positive \u03b3\u03b4 T-cell lymphoma vs. extranodal NK\/T-cell lymphoma: a case report and literature review","volume":"40","author":"Yu","year":"2013","journal-title":"J\u00a0Cutan Pathol"},{"issue":"2","key":"10.1016\/j.hoc.2018.08.004_bib13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/DAD.0b013e318289b1db","article-title":"Cutaneous lymphomas: an update. Part 1: T-cell and natural killer\/t-cell lymphomas and related conditions","volume":"36","author":"Kempf","year":"2014","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.hoc.2018.08.004_bib14","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1038\/ncomms7025","article-title":"Activating mutations of STAT5B and STAT3 in lymphomas derived from \u03b3\u03b4-T or NK cells","volume":"6","author":"K\u00fc\u00e7\u00fck","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.hoc.2018.08.004_bib15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3816\/CLM.2008.n.005","article-title":"Cutaneous \u03b3\/\u03b4 T-cell lymphoma treated with radiation and denileukin diftitox","volume":"8","author":"Vidulich","year":"2008","journal-title":"Clin Lymphoma Myeloma"},{"issue":"2","key":"10.1016\/j.hoc.2018.08.004_bib16","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/j.clml.2015.11.013","article-title":"A\u00a0single-center experience with brentuximab vedotin in gamma delta T-cell lymphoma","volume":"16","author":"Talpur","year":"2016","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"12","key":"10.1016\/j.hoc.2018.08.004_bib17","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1001\/jamadermatol.2016.3117","article-title":"Cutaneous gamma-delta T-cell lymphoma successfully treated with brentuximab vedotin","volume":"152","author":"Rubio-Gonzalez","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10.1016\/j.hoc.2018.08.004_bib18","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/modpathol.2008.40","article-title":"Primary cutaneous CD4-positive small\/medium-sized pleomorphic T-cell lymphoma: a clonal T-cell lymphoproliferative disorder with indolent behavior","volume":"21","author":"Grogg","year":"2008","journal-title":"Mod Pathol"},{"issue":"20","key":"10.1016\/j.hoc.2018.08.004_bib19","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1200\/JCO.2008.16.1307","article-title":"Primary cutaneous small\/medium CD4+ T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome","volume":"26","author":"Garcia-Herrera","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2018.08.004_bib20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/PAS.0b013e31818e52fe","article-title":"Primary cutaneous CD4+ small\/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers","volume":"33","author":"Rodr\u00edguez Pinilla","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.hoc.2018.08.004_bib21","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/ijd.13340","article-title":"Long-term follow-up and management of small and medium-sized CD4+ T\u00a0cell lymphoma and CD8+ lymphoid proliferations of acral sites: a multicenter experience","volume":"55","author":"Virmani","year":"2016","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.hoc.2018.08.004_bib22","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3109\/10428194.2014.938331","article-title":"CD4\u00a0+ primary cutaneous small\/medium-sized pleomorphic T-cell lymphoma: a retrospective case series and review of literature","volume":"56","author":"James","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.hoc.2018.08.004_bib23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/DAD.0b013e31819f19bb","article-title":"Primary cutaneous CD4+ small-\/medium-sized pleomorphic T-cell lymphoma: a cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance? A study of 136 cases","volume":"31","author":"Beltraminelli","year":"2009","journal-title":"Am J Dermatopathol"},{"issue":"10","key":"10.1016\/j.hoc.2018.08.004_bib24","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.5858\/arpa.2014-0299-CC","article-title":"Controversies and considerations in the diagnosis of primary cutaneous CD4+ small\/medium T-cell lymphoma","volume":"138","author":"Lan","year":"2014","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.hoc.2018.08.004_bib25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.12788\/j.sder.2018.006","article-title":"Primary cutaneous CD4+ small\/medium T-cell lymphoproliferative disorder-clinical and histopathologic features, differential diagnosis, and treatment","volume":"37","author":"Gru","year":"2018","journal-title":"Semin Cutan Med Surg"},{"issue":"1","key":"10.1016\/j.hoc.2018.08.004_bib26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/PAS.0b013e318230df87","article-title":"Expression of programmed death-1 in primary cutaneous CD4-positive small\/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma","volume":"36","author":"Cetin\u00f6zman","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.hoc.2018.08.004_bib27","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1001\/jamadermatol.2013.4162","article-title":"Primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoma: temporary remission by oral doxycycline","volume":"149","author":"Toberer","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"20","key":"10.1016\/j.hoc.2018.08.004_bib28","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2018.08.004_bib29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/cup.12633","article-title":"Indolent CD8-positive lymphoid proliferation of acral sites: three further cases of a rare entity and an update on a unique patient","volume":"43","author":"Kluk","year":"2016","journal-title":"J\u00a0Cutan Pathol"},{"issue":"2","key":"10.1016\/j.hoc.2018.08.004_bib30","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/cup.12045","article-title":"Indolent CD8(+) lymphoid proliferation of acral sites: a clinicopathologic study of six patients with some atypical features","volume":"40","author":"Greenblatt","year":"2013","journal-title":"J\u00a0Cutan Pathol"},{"issue":"11","key":"10.1016\/j.hoc.2018.08.004_bib31","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/cup.12213","article-title":"Extrafacial indolent CD8-positive cutaneous lymphoid proliferation with unusual symmetrical presentation involving both feet","volume":"40","author":"Wobser","year":"2013","journal-title":"J\u00a0Cutan Pathol"},{"issue":"11","key":"10.1016\/j.hoc.2018.08.004_bib32","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.5858\/arpa.2017-0230-RA","article-title":"Primary cutaneous acral CD8+ T-cell lymphoma","volume":"141","author":"Hathuc","year":"2017","journal-title":"Arch Pathol Lab Med"},{"issue":"12","key":"10.1016\/j.hoc.2018.08.004_bib33","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1097\/PAS.0b013e318068b527","article-title":"Indolent CD8-positive lymphoid proliferation of the ear: a distinct primary cutaneous T-cell lymphoma?","volume":"31","author":"Petrella","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.hoc.2018.08.004_bib34","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/bjd.13628","article-title":"CD68 expression is a discriminative feature of indolent cutaneous CD8-positive lymphoid proliferation and distinguishes this lymphoma subtype from other CD8-positive cutaneous lymphomas","volume":"172","author":"Wobser","year":"2015","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.hoc.2018.08.004_bib35","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/DAD.0b013e31825c3a33","article-title":"Primary cutaneous CD8(+) small- to medium-sized lymphoproliferative disorder in extrafacial sites: clinicopathologic features and concept on their classification","volume":"35","author":"Kempf","year":"2013","journal-title":"Am J Dermatopathol"},{"issue":"4","key":"10.1016\/j.hoc.2018.08.004_bib36","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/his.12371","article-title":"Aggressive epidermotropic cutaneous CD8+ lymphoma: a cutaneous lymphoma with distinct clinical and pathological features. Report of an EORTC Cutaneous Lymphoma Task Force Workshop","volume":"67","author":"Robson","year":"2015","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.hoc.2018.08.004_bib37","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jaad.2011.07.043","article-title":"Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: proposed diagnostic criteria and therapeutic evaluation","volume":"67","author":"Nofal","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.hoc.2018.08.004_bib38","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/modpathol.2016.240","article-title":"Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas","volume":"30","author":"Guitart","year":"2017","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.hoc.2018.08.004_bib39","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0002-9440(10)65144-9","article-title":"Primary cutaneous CD8-positive epidermotropic cytotoxic T\u00a0cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior","volume":"155","author":"Berti","year":"1999","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.hoc.2018.08.004_bib40","first-page":"441","article-title":"Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma with a CD15(+)CD30(-) phenotype","volume":"17","author":"Yoshizawa","year":"2007","journal-title":"Eur J Dermatol"},{"issue":"9","key":"10.1016\/j.hoc.2018.08.004_bib41","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1346-8138.2006.00147.x","article-title":"Primary cutaneous aggressive epidermotropic CD8(+) cytotoxic T-cell lymphoma with atypical presentation","volume":"33","author":"Kim","year":"2006","journal-title":"J\u00a0Dermatol"},{"issue":"2","key":"10.1016\/j.hoc.2018.08.004_bib42","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s12185-015-1895-9","article-title":"Molecular genetic and cytogenetic analysis of a primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma","volume":"103","author":"Kato","year":"2016","journal-title":"Int J Hematol"},{"issue":"1","key":"10.1016\/j.hoc.2018.08.004_bib43","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1016\/j.clml.2017.11.004","article-title":"Transplantation in the treatment of primary cutaneous aggressive epidermotropic cytotoxic CD8-positive T-cell lymphoma","volume":"18","author":"Cyrenne","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"2","key":"10.1016\/j.hoc.2018.08.004_bib44","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jaad.2009.02.035","article-title":"Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma","volume":"62","author":"Gormley","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"Suppl 6","key":"10.1016\/j.hoc.2018.08.004_bib45","doi-asserted-by":"crossref","first-page":"vi149","DOI":"10.1093\/annonc\/mdt242","article-title":"Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Willemze","year":"2013","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.hoc.2018.08.004_bib46","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1200\/JCO.2015.63.5540","article-title":"Racial patterns of peripheral T-cell lymphoma incidence and survival in the United States","volume":"34","author":"Adams","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"17","key":"10.1016\/j.hoc.2018.08.004_bib47","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","article-title":"Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project","volume":"113","author":"Au","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2018.08.004_bib48","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/PAS.0b013e31824433d8","article-title":"Extranodal NK\/T-cell lymphoma, nasal type, includes cases of natural killer cell and \u03b1\u03b2, \u03b3\u03b4, and \u03b1\u03b2\/\u03b3\u03b4 T-cell origin: a comprehensive clinicopathologic and phenotypic study","volume":"36","author":"Pongpruttipan","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.hoc.2018.08.004_bib49","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1158\/1078-0432.CCR-08-2914","article-title":"Variable clinical presentations of nasal and Waldeyer ring natural killer\/T-cell lymphoma","volume":"15","author":"Li","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.hoc.2018.08.004_bib50","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.hoc.2016.11.007","article-title":"Clinical features and current optimal management of natural killer\/T-cell lymphoma","volume":"31","author":"Makita","year":"2017","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"10.1016\/j.hoc.2018.08.004_bib51","first-page":"29","article-title":"Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer\/T-cell lymphoma","volume":"8","author":"Lei","year":"2002","journal-title":"Clin Cancer Res"},{"issue":"7","key":"10.1016\/j.hoc.2018.08.004_bib52","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00277-007-0278-6","article-title":"Lymphoma-associated hemophagocytic syndrome: clinical features and treatment outcome","volume":"86","author":"Han","year":"2007","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.hoc.2018.08.004_bib53","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00000478-199601000-00012","article-title":"Report of the workshop on nasal and related extranodal angiocentric T\/natural killer cell lymphomas. Definitions, differential diagnosis, and epidemiology","volume":"20","author":"Jaffe","year":"1996","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.hoc.2018.08.004_bib54","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/annonc\/mdp418","article-title":"Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type","volume":"21","author":"Suzuki","year":"2010","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.hoc.2018.08.004_bib55","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/annonc\/mdh268","article-title":"CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature","volume":"15","author":"Bekkenk","year":"2004","journal-title":"Ann Oncol"},{"issue":"17","key":"10.1016\/j.hoc.2018.08.004_bib56","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1182\/blood-2016-12-756841","article-title":"PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK\/T-cell lymphoma failing l-asparaginase","volume":"129","author":"Kwong","year":"2017","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.hoc.2018.08.004_bib57","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.0303-6987.2006.00493.x","article-title":"The protean spectrum of non-Hodgkin lymphomas with prominent involvement of subcutaneous fat","volume":"33","author":"Massone","year":"2006","journal-title":"J Cutan Pathol"},{"issue":"9","key":"10.1016\/j.hoc.2018.08.004_bib58","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1038\/jid.2008.6","article-title":"Clinicopathological characterization and genomic aberrations in subcutaneous panniculitis-like T-cell lymphoma","volume":"128","author":"Hahtola","year":"2008","journal-title":"J\u00a0Invest Dermatol"},{"issue":"6","key":"10.1016\/j.hoc.2018.08.004_bib59","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/cncr.20502","article-title":"Immunophenotypic and molecular features, clinical outcomes, treatments, and prognostic factors associated with subcutaneous panniculitis-like T-cell lymphoma: a systematic analysis of 156 patients reported in the literature","volume":"101","author":"Go","year":"2004","journal-title":"Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2018.08.004_bib60","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1038\/modpathol.2012.181","article-title":"Peripheral T-cell and NK-cell lymphomas in the WHO classification: pearls and pitfalls","volume":"26","author":"Jaffe","year":"2013","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.hoc.2018.08.004_bib61","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/01.dad.0000187933.87103.03","article-title":"Rimming of adipocytes by neoplastic lymphocytes: a histopathologic feature not restricted to subcutaneous T-cell lymphoma","volume":"28","author":"Lozzi","year":"2006","journal-title":"Am J Dermatopathol"},{"issue":"3","key":"10.1016\/j.hoc.2018.08.004_bib62","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00000372-200106000-00008","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: an elusive case presenting as lipomembranous panniculitis and a review of 72 cases in the literature","volume":"23","author":"Weenig","year":"2001","journal-title":"Am J Dermatopathol"},{"issue":"5","key":"10.1016\/j.hoc.2018.08.004_bib63","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1365-2133.2010.09951.x","article-title":"Subcutaneous panniculitis-like T-cell lymphoma \u03b1\u03b2: complete sustained remission with corticosteroids and methotrexate","volume":"163","author":"Briki","year":"2010","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.hoc.2018.08.004_bib64","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.clml.2011.06.016","article-title":"Bexarotene is active against subcutaneous panniculitis-like T-cell lymphoma in adult and pediatric populations","volume":"12","author":"Mehta","year":"2012","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"8","key":"10.1016\/j.hoc.2018.08.004_bib65","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3816\/CLM.2007.n.040","article-title":"Efficacy of denileukin diftitox in subcutaneous panniculitis-like T-cell lymphoma","volume":"7","author":"Hathaway","year":"2007","journal-title":"Clin Lymphoma Myeloma"},{"issue":"3","key":"10.1016\/j.hoc.2018.08.004_bib66","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4143\/crt.2014.46.3.312","article-title":"Cyclosporine a as a primary treatment for panniculitis-like T\u00a0cell lymphoma: a case with a long-term remission","volume":"46","author":"Lee","year":"2014","journal-title":"Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.hoc.2018.08.004_bib67","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4143\/crt.2011.43.4.255","article-title":"Cyclosporine in relapsed subcutaneous panniculitis-like T-cell lymphoma after autologous hematopoietic stem cell transplantation","volume":"43","author":"Jung","year":"2011","journal-title":"Cancer Res Treat"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858818307822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858818307822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:10:47Z","timestamp":1760184647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858818307822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0889858818307822"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2018.08.004","relation":{},"ISSN":["0889-8588"],"issn-type":[{"type":"print","value":"0889-8588"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rare Cutaneous T-Cell Lymphomas","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2018.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}